Consonance Capital Partners, a leading U.S.-based healthcare private equity firm, has announced the final close of Consonance Private Equity II, L.P. (Fund II). Fund II closed at its hard cap of $856 million (inclusive of the GP commitment) in under three months from its initial close. Consistent with its predecessor fund, Fund II will focus on investments in U.S. healthcare companies in the lower and middle markets.
Latham & Watkins LLP advised Consonance Capital Partners on the fund formation with a team led by New York Investment Funds partner Andrea Schwartzman, with associates Erin Bergey, John Welling, and Connor Ross. New York partner Gregory Hannibal, with associate Eli McCrain, advised on tax matters.